Banerjee A - Search Results

1

Mitochondrial genome analysis of primary open angle glaucoma patients.

Banerjee D, Banerjee A, Mookherjee S, Vishal M, Mukhopadhyay A, Sen A, Basu A, Ray K. Banerjee D, et al. Among authors: banerjee a. PLoS One. 2013 Aug 5;8(8):e70760. doi: 10.1371/journal.pone.0070760. Print 2013. PLoS One. 2013. PMID: 23940637 Free PMC article.

2

Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.

Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, Ray A, Sen A; Indian Genome Variation Consortium; Ray K. Bhattacharjee A, et al. Among authors: banerjee a, banerjee d. Mol Vis. 2008 May 8;14:841-50. Mol Vis. 2008. PMID: 18483560 Free PMC article.

3

Association of IL1A and IL1B loci with primary open angle glaucoma.

Mookherjee S, Banerjee D, Chakraborty S, Banerjee A, Mukhopadhyay I, Sen A, Ray K. Mookherjee S, et al. Among authors: banerjee a, banerjee d. BMC Med Genet. 2010 Jun 19;11:99. doi: 10.1186/1471-2350-11-99. BMC Med Genet. 2010. PMID: 20565898 Free PMC article.

4

Functional and Structural Analyses of CYP1B1 Variants Linked to Congenital and Adult-Onset Glaucoma to Investigate the Molecular Basis of These Diseases.

Banerjee A, Chakraborty S, Chakraborty A, Chakrabarti S, Ray K. Banerjee A, et al. PLoS One. 2016 May 31;11(5):e0156252. doi: 10.1371/journal.pone.0156252. eCollection 2016. PLoS One. 2016. PMID: 27243976 Free PMC article.

5

Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Banerjee A, De M, Ali N. Banerjee A, et al. Antimicrob Agents Chemother. 2011 Apr;55(4):1661-70. doi: 10.1128/AAC.00524-10. Epub 2011 Jan 10. Antimicrob Agents Chemother. 2011. PMID: 21220536 Free PMC article.

6

Immune responses in kala-azar.

Saha S, Mondal S, Banerjee A, Ghose J, Bhowmick S, Ali N. Saha S, et al. Among authors: banerjee a. Indian J Med Res. 2006 Mar;123(3):245-66. Indian J Med Res. 2006. PMID: 16778308 Free article. Review.

7

Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses.

Banerjee A, De M, Ali N. Banerjee A, et al. J Immunol. 2008 Jul 15;181(2):1386-98. doi: 10.4049/jimmunol.181.2.1386. J Immunol. 2008. PMID: 18606693

8

Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine.

Banerjee A, Roychoudhury J, Ali N. Banerjee A, et al. J Antimicrob Chemother. 2008 Jan;61(1):103-10. doi: 10.1093/jac/dkm396. Epub 2007 Oct 26. J Antimicrob Chemother. 2008. PMID: 17965031

9

Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.

Asad M, Bhattacharya P, Banerjee A, Ali N. Asad M, et al. Among authors: banerjee a. BMC Infect Dis. 2015 Apr 17;15:188. doi: 10.1186/s12879-015-0928-6. BMC Infect Dis. 2015. PMID: 25884796 Free PMC article.

10

Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.

Mazumder S, Ravindran R, Banerjee A, Ali N. Mazumder S, et al. Among authors: banerjee a. Vaccine. 2007 Dec 17;25(52):8771-81. doi: 10.1016/j.vaccine.2007.10.028. Epub 2007 Nov 5. Vaccine. 2007. PMID: 18031874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,103 results

Search Page

Filters